|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
7 months to Dec 31, 2020
|
|
|---|---|---|---|---|
| Revenue (inclusive of $55,688, $46,605, and $77,221 of related party revenue for the years ended December 31, 2023, 2022, and 2021, respectively) | ||||
| Costs and operating expenses: | ||||
| Costs of revenue (exclusive of depreciation and amortization; inclusive of $28,634, $18,010, and $0 of related party costs of revenue for the years ended December 31, 2023, 2022, and 2021, respectively) | ||||
| Sales and marketing | ||||
| Product and technology | ||||
| General and administrative | ||||
| Depreciation and amortization | ||||
| Total costs and operating expenses | ||||
| Loss from operations | ||||
| Other income (expense): | ||||
| Interest income | ||||
| Interest expense | ||||
| Loss on extinguishment of debt | ||||
| Other income | ||||
| Total other income (expense) | ||||
| Loss before income tax benefit | ||||
| Income tax benefit | ||||
| Loss from equity method investment | ||||
| Net loss | ||||
| Foreign currency translation | ||||
| Comprehensive loss | ||||
| Comprehensive loss attributable to non-controlling interest in subsidiaries | ||||
| Comprehensive loss attributable to Sharecare, Inc. | ||||
| Net loss attributable to non-controlling interest in subsidiaries | ||||
| Net loss attributable to Sharecare, Inc. | ||||
| Net Loss per Share | ||||
| Net loss per share attributable to common stockholders, basic (in USD per share) | ||||
| Net loss per share attributable to common stockholders, diluted (in USD per share) | ||||
| Weighted-average common shares outstanding, basic (in shares) | ||||
| Weighted-average common shares outstanding, diluted (in shares) | ||||
Loading...